LGND You've reached a level of minutia that my mind and even website lacks, but probably is in my files somewhere. But from memory, I believe the SGP-PCOP deal would have involved SGP gaining rights to screen PCOP's chemical library for potential inhibitors of a list of targets of interest. If that is the case, I would feel strongly about single digits, but I am not sure without further digging
PCOP did not bring any drug candidates to the table in the SGP collaboaration. Only leads, that required extensive med chem efforts, to have sufficient drug-like properties.
Market Data 
Markets 
AI
